ICON Research gains a regulatory expert, plus new executives for Exco InTouch, Avillion and others.
ICON has appointed Mary Pendergast, a regulatory expert, to a non-executive role on its board of directors.
The new director is also president of Pendergast Consulting, a firm which provides communications advice to biopharmaceutical companies. Previously, she was Executive VP of Government Affairs at Irish drug firm Elan, and a deputy commissioner at the US FDA.
Ms. Pendergast is also a board member of AesRx, ARCH Foundation and Impax Laboratories.
Copyright - Unless otherwise stated all contents of this web site are © 2016 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Quintiles has opened the global Solution Design Studio at its campus in Research Triangle Park in North...
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the...